LymeNet - The LymeNet Newsletter

LymeNet Newsletter

Lyme Disease is one of the fastest growing infectious diseases in the United States. In 20 short years, this little known bacterial infection has claimed at least a million victims and the number of new patients continues to spiral upward with no relief in sight. If left untreated, LD can cause permanent nerve, musculoskeletal and cardiac damage.

Unfortunately, we know relatively little about this tick-borne ailment. The bacterial agent that causes LD, Borrelia burgdorferi, is poorly understood and continues to challenge scientists and physicians alike. The confusion and ambiguity have produced controversy.

Many experts in the academic community have declared that LD can always be cured with short courses of simple antibiotics. However, as the number of cases rise, doctors on the front lines are discovering that LD is more serious than previously suspected, requiring longer treatment therapies and more complex combinations of medicines. The battle lines have been drawn. And the battles continue at LD conferences, and in the various State legislatures where insurance companies, terrified at the high cost of LD, are attempting to cut off patients. The LymeNet Newsletter was designed to present readers with up-to-date developments, including new treatment protocols, research news and political events.

The LymeNet Newsletter is no longer published. Only back issues are available.

BACK ISSUES:

Questions about Lyme disease? Contact Carol Stolow at: carol_stolow@lymenet.org (carol_stolow@lymenet.org)

Technical questions or comments about this home page? Send them to Marc Gabriel at: a229@lehigh.edu